Mind Medicine (MindMed) Inc (MNMD)

[PyroStocks]

US20210267977 - CONTROLLING EFFECTS AFTER 5HT2A AGONISTS ADMINISTRATION

https://patentscope.wipo.int/search/en/detail.jsf?docId=US335021377&_cid=P12-L7M9HD-95208-3

Office
United States of America
Application Number
17156233
Application Date
22.01.2021
Publication Number
20210267977
Publication Date
02.09.2021
Publication Kind
A1
IPC
A61K 31/517 A61K 31/48 A61P 25/26
CPC
A61P 25/26 A61K 31/517 A61K 31/48
Applicants
Universitätsspital Basel
Inventors
Matthias Emanuel LIECHTI
Title
(EN) CONTROLLING EFFECTS AFTER 5HT2A AGONISTS ADMINISTRATION
front page image
Abstract
(EN)
A composition for treating an individual while reducing acute effects, including effective amounts of a psychedelic drug and a duration shortening agent. A method of treating an individual with a psychedelic drug and reducing its acute duration of action, by administering a psychedelic drug to the individual, administering a duration shortening agent to the individual, and shortening and/or reducing the acute effects of the psychedelic drug. A method of stopping the acute duration of action of a psychedelic drug in an individual, by administering a duration shortening agent to the individual after the individual has taken a psychedelic drug and stopping the acute effects of the psychedelic drug.